An agenda for research on adverse drug reactions.

An agenda for research on adverse drug reactions.

Opis bibliograficzny
1. autor:	Aronson, J
Format:	Journal article
Język:	English
Wydane:	2007

Podobne zapisy

Pharmacogenetics and adverse drug reactions
od: Ferner, R, i wsp.
Wydane: (2010)

Adverse drug reactions--no farewell to harms.
od: Aronson, J
Wydane: (2007)

Publishing histories of adverse reactions to medicaments anecdotally: the PHARMA guidelines for reporting suspected adverse drug reactions.
od: Aronson, J
Wydane: (2008)

Adverse drug reactions: definitions, diagnosis, and management.
od: Edwards, I, i wsp.
Wydane: (2000)

Adverse drug reactions: keeping up to date.
od: Aronson, J, i wsp.
Wydane: (2002)

Distinguishing hazards and harms, adverse drug effects and adverse drug reactions : implications for drug development, clinical trials, pharmacovigilance, biomarkers, and monitoring.
od: Aronson, J
Wydane: (2013)

National differences in publishing papers on adverse drug reactions.
od: Ferner, R, i wsp.
Wydane: (2005)

Paradoxical reactions: Under-recognized adverse effects of drugs?
od: Hauben, M, i wsp.
Wydane: (2006)

Adverse Drug Reactions: History, Terminology, Classification, Causality, Frequency, Preventability
od: Aronson, J
Wydane: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
od: Talbot, J, i wsp.
Wydane: (2012)

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
od: Talbot, J, i wsp.
Wydane: (2012)

Meyler's side effects of drugs : the international encyclopedia of adverse drug reactions and interactions /
od: Aronson, Jeffrey K.
Wydane: (2006)

Joining the DoTS: new approach to classifying adverse drug reactions.
od: Aronson, J, i wsp.
Wydane: (2003)

Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.
od: Aronson, J
Wydane: (2005)

Preventability of drug-related harms - part II: proposed criteria, based on frameworks that classify adverse drug reactions.
od: Aronson, J, i wsp.
Wydane: (2010)

A practical guide to monitoring for adverse drug reactions during antihypertensive drug therapy.
od: McDowell, SE, i wsp.
Wydane: (2013)

Stephens' detection and evaluation of adverse drug reactions : principles and practice /
od: Talbot, J. C. C., i wsp.
Wydane: (2012)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
od: Derry, S, i wsp.
Wydane: (2001)

Incomplete evidence: The inadequacy of databases in tracing published adverse drug reactions in clinical trials
od: Derry, S, i wsp.
Wydane: (2001)

Case reports of suspected adverse drug reactions--systematic literature survey of follow-up.
od: Loke, Y, i wsp.
Wydane: (2006)

Post-marketing withdrawal of analgesic medications because of adverse drug reactions: a systematic review
od: Onakpoya, I, i wsp.
Wydane: (2017)

Worldwide withdrawal of medicinal products because of adverse drug reactions: a systematic review and analysis
od: Onakpoya, I, i wsp.
Wydane: (2016)

Gold standards in pharmacovigilance: the use of definitive anecdotal adverse drug reactions as pure gold and high grade ore
od: Hauben, M, i wsp.
Wydane: (2006)

Adverse drug reactions
od: AA Moghadam Nia
Wydane: (1999-01-01)

Incomplete evidence: the inadequacy of databases in tracing published adverse drug reactions in clinical trials
od: Aronson Jeffrey K, i wsp.
Wydane: (2001-09-01)

Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore.
od: Hauben, M, i wsp.
Wydane: (2007)

Monitoring for the Adverse Effects of Drugs
od: Coleman, J, i wsp.
Wydane: (2008)

Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review.
od: Onakpoya, I, i wsp.
Wydane: (2016)

Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
od: Daniele Sartori, i wsp.
Wydane: (2020-08-01)

Clinical pharmacology. Adverse drug interactions.
od: Aronson, J, i wsp.
Wydane: (1981)

Adverse cutaneous drug reaction
od: Nayak Surajit, i wsp.
Wydane: (2008-01-01)

Adverse cutaneous drug reactions
od: Neda Adibi
Wydane: (2014-01-01)

Research Progress on Mechanism and Management of Adverse Drug Reactions of Anlotinib
od: Li S, i wsp.
Wydane: (2023-11-01)

Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale
od: Samet Kose, i wsp.
Wydane: (2017-04-01)

Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis.
od: Katja M Hakkarainen, i wsp.
Wydane: (2012-01-01)

EIDOS: a mechanistic classification of adverse drug effects.
od: Ferner, R, i wsp.
Wydane: (2010)

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
od: Onakpoya, IJ, i wsp.
Wydane: (2016)

Pharmacovigilance and reporting adverse drug reactions.
od: Isa NM,
Wydane: (2014)

Children and ADRs (Adverse Drug Reactions)
od: Napoleone Ettore
Wydane: (2010-01-01)

Adverse Drug Reactions in the Oral Cavity
od: Danko Velimir Vrdoljak, i wsp.
Wydane: (2015-01-01)